2020 Q1 Form 10-Q Financial Statement

#000143462120000025 Filed on May 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $283.1M $262.4M
YoY Change 7.89% 44.94%
Cost Of Revenue $14.25M $17.67M
YoY Change -19.34% 210.22%
Gross Profit $109.2M $106.5M
YoY Change 2.53% -39.25%
Gross Profit Margin 38.58% 40.6%
Selling, General & Admin $227.6M $206.0M
YoY Change 10.49% 38.39%
% of Gross Profit 208.41% 193.4%
Research & Development $10.96M $10.17M
YoY Change 7.84% 62.4%
% of Gross Profit 10.04% 9.54%
Depreciation & Amortization $3.378M $2.482M
YoY Change 36.1% 48.53%
% of Gross Profit 3.09% 2.33%
Operating Expenses $238.6M $216.2M
YoY Change 10.37% 39.36%
Operating Profit $20.75M -$1.802M
YoY Change -1251.44% -111.74%
Interest Expense $4.834M $5.468M
YoY Change -11.59% -282.27%
% of Operating Profit 23.3%
Other Income/Expense, Net $0.00 $68.00K
YoY Change -100.0% 100.0%
Pretax Income $15.92M -$7.202M
YoY Change -320.98% -158.1%
Income Tax -$3.061M -$7.752M
% Of Pretax Income -19.23%
Net Earnings $14.40M -$500.0K
YoY Change -2980.0% -101.59%
Net Earnings / Revenue 5.09% -0.19%
Basic Earnings Per Share $1.11 -$0.04
Diluted Earnings Per Share $1.02 -$0.04
COMMON SHARES
Basic Shares Outstanding 12.96M shares 12.72M shares
Diluted Shares Outstanding 14.16M shares 14.19M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.20M $64.60M
YoY Change -20.74% -81.36%
Cash & Equivalents $51.21M $64.57M
Short-Term Investments
Other Short-Term Assets $17.60M $34.70M
YoY Change -49.28% 93.85%
Inventory
Prepaid Expenses
Receivables $119.6M $119.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $188.3M $219.0M
YoY Change -14.0% -48.96%
LONG-TERM ASSETS
Property, Plant & Equipment $31.47M $25.82M
YoY Change 21.88% -31.25%
Goodwill $420.1M $420.0M
YoY Change 0.04% 270.43%
Intangibles $167.8M $223.9M
YoY Change -25.04% 190.61%
Long-Term Investments $80.00M
YoY Change
Other Assets $28.67M $13.30M
YoY Change 115.48% 588.2%
Total Long-Term Assets $828.3M $773.5M
YoY Change 7.08% 178.52%
TOTAL ASSETS
Total Short-Term Assets $188.3M $219.0M
Total Long-Term Assets $828.3M $773.5M
Total Assets $1.017B $992.5M
YoY Change 2.43% 40.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.100M $12.20M
YoY Change -50.0% 159.57%
Accrued Expenses $105.6M $106.0M
YoY Change -0.34% 35.65%
Deferred Revenue $700.0K $600.0K
YoY Change 16.67%
Short-Term Debt $130.0M $185.0M
YoY Change -29.73%
Long-Term Debt Due $130.0M $185.0M
YoY Change -29.73%
Total Short-Term Liabilities $292.3M $350.3M
YoY Change -16.55% 172.19%
LONG-TERM LIABILITIES
Long-Term Debt $267.9M $254.2M
YoY Change 5.36% 5.35%
Other Long-Term Liabilities $24.75M $16.20M
YoY Change 52.79% 905.4%
Total Long-Term Liabilities $292.6M $270.4M
YoY Change 8.2% 11.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $292.3M $350.3M
Total Long-Term Liabilities $292.6M $270.4M
Total Liabilities $593.1M $640.3M
YoY Change -7.38% 69.9%
SHAREHOLDERS EQUITY
Retained Earnings -$578.3M -$611.0M
YoY Change -5.36% -13.58%
Common Stock $1.185B $1.145B
YoY Change 3.5% 3.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $183.2M $181.7M
YoY Change 0.82% 89.07%
Treasury Stock Shares 2.641M shares 2.636M shares
Shareholders Equity $423.6M $352.2M
YoY Change
Total Liabilities & Shareholders Equity $1.017B $992.5M
YoY Change 2.43% 40.43%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $14.40M -$500.0K
YoY Change -2980.0% -101.59%
Depreciation, Depletion And Amortization $3.378M $2.482M
YoY Change 36.1% 48.53%
Cash From Operating Activities $28.60M $20.40M
YoY Change 40.2% 36.0%
INVESTING ACTIVITIES
Capital Expenditures -$4.200M -$5.000M
YoY Change -16.0% 42.86%
Acquisitions
YoY Change
Other Investing Activities -$80.00M $0.00
YoY Change -100.0%
Cash From Investing Activities -$84.19M -$110.4M
YoY Change -23.75% 3054.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $3.976M
YoY Change -100.0% -67.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $46.60M $49.41M
YoY Change -5.68% -247.05%
NET CHANGE
Cash From Operating Activities 28.60M 20.40M
Cash From Investing Activities -$84.19M -$110.4M
Cash From Financing Activities $46.60M $49.41M
Net Change In Cash -$37.59M -$61.00M
YoY Change -38.38% 176.0%
FREE CASH FLOW
Cash From Operating Activities $28.60M $20.40M
Capital Expenditures -$4.200M -$5.000M
Free Cash Flow $32.80M $25.40M
YoY Change 29.13% 37.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.32
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001434621
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17979000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19294000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1466000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2021000 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15676819 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15704064 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13035501 shares
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
195538000 USD
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13062746 shares
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2641318 shares
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2641318 shares
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-34063
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
LendingTree, Inc.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2414818
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
11115 Rushmore Drive
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Charlotte
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28277
CY2020Q1 dei City Area Code
CityAreaCode
704
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
541-5351
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2020Q1 dei Trading Symbol
TradingSymbol
TREE
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13063927 shares
CY2020Q1 us-gaap Revenues
Revenues
283084000 USD
CY2019Q1 us-gaap Revenues
Revenues
262390000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
14252000 USD
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
17670000 USD
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
174891000 USD
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.07
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32082000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31117000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10963000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10166000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3378000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2482000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13757000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13427000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8122000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
14592000 USD
CY2020Q1 us-gaap Severance Costs1
SeveranceCosts1
158000 USD
CY2019Q1 us-gaap Severance Costs1
SeveranceCosts1
54000 USD
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-329000 USD
CY2019Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
207000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
262335000 USD
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
264192000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20749000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1802000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4834000 USD
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5468000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15915000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7202000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3061000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7752000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
18976000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
550000 USD
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4575000 USD
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1062000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14401000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-512000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12957000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12718000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14158000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14186000 shares
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.46
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.34
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.35
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.08
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51208000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60243000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
93000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
96000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
119559000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113487000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17375000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15516000 USD
CY2020Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
84000 USD
CY2019Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
84000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
188319000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
189426000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31473000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31363000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
420139000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
420139000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
167823000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
181580000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
90725000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
87664000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
80000000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28665000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29849000 USD
CY2020Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
9476000 USD
CY2019Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
7948000 USD
CY2020Q1 us-gaap Assets
Assets
1016620000 USD
CY2019Q4 us-gaap Assets
Assets
947969000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
130000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
75000000 USD
CY2020Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
6056000 USD
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2873000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105647000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
112755000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
14183000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
9028000 USD
CY2020Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
36400000 USD
CY2019Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
31050000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
292286000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
230706000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
267870000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
264391000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
8159000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
24436000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24748000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26110000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
593063000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
545643000 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
157000 USD
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
157000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1184813000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1177984000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-578252000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-592654000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
183161000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
183161000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
423557000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
402326000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1016620000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
947969000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
402326000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-11917000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-5087000 USD
CY2020Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
423557000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
346208000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-14053000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3976000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3585000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
352188000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14401000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-512000 USD
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4575000 USD
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1062000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
18976000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
550000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-530000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-468000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13757000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13427000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3378000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2482000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11917000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14053000 USD
CY2020Q1 tree Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-3061000 USD
CY2019Q1 tree Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-7752000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8122000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
14592000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
880000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
510000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
582000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
483000 USD
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3111000 USD
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2951000 USD
CY2020Q1 tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-196000 USD
CY2019Q1 tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
35000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6952000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27534000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1430000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
207000 USD
CY2020Q1 tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-3271000 USD
CY2019Q1 tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
5653000 USD
CY2020Q1 tree Contingent Consideration Payment
ContingentConsiderationPayment
0 USD
CY2019Q1 tree Contingent Consideration Payment
ContingentConsiderationPayment
1000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
65000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4288000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
862000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-270000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
29302000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
23269000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4189000 USD
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4960000 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
80000000 USD
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-84189000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110405000 USD
CY2020Q1 tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-5087000 USD
CY2019Q1 tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-3585000 USD
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3000000 USD
CY2019Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3000000 USD
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
55000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000 USD
CY2019Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
60000000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
306000 USD
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
31000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3976000 USD
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46601000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49408000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-8286000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-37728000 USD
CY2020Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-752000 USD
CY2019Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2827000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-752000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-2827000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9038000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-40555000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60339000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105158000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51301000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64603000 USD
CY2020Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2019Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
852000 USD
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Estimates</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant estimates underlying the accompanying consolidated financial statements, including discontinued operations, include: loan loss obligations; the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business </span></div>combination; contingent consideration related to business combinations; litigation accruals; HLC ownership related claims; contract assets; various other allowances, reserves and accruals; and assumptions related to the determination of stock-based compensation.
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Certain Risks and Concentrations</span></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and credit card fraud.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments, which potentially subject the Company to concentration of credit risk at </span><span style="font-family:inherit;font-size:10pt;">March 31, 2020</span><span style="font-family:inherit;font-size:10pt;">, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which in the event of non-payment, would be applied against any accounts receivable outstanding.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its services.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.</span></div>
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60339000 USD
CY2020Q1 us-gaap Revenues
Revenues
283084000 USD
CY2019Q1 us-gaap Revenues
Revenues
262390000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6800000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6500000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
700000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
600000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 USD
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 USD
CY2020Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
100000 USD
CY2019Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
900000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51208000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60243000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
93000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
96000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51301000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
420139000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1466000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1143000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
880000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
510000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
332000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
288000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
7000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
5000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2021000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1370000 USD
CY2020Q1 us-gaap Goodwill Gross
GoodwillGross
903227000 USD
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
903227000 USD
CY2020Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 USD
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
420139000 USD
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
157681000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
171438000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
167823000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
181580000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
261705000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
104024000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
157681000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
261705000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
90267000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
171438000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
39322000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
42738000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
25256000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8602000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
6747000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
35016000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
157681000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8122000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
14592000 USD
CY2020Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
58165000 USD
CY2019Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
65836000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9265000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10540000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3315000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1560000 USD
CY2020Q1 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
9616000 USD
CY2019Q4 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
6920000 USD
CY2020Q1 tree Charitable Contribution Accrual
CharitableContributionAccrual
3333000 USD
CY2019Q4 tree Charitable Contribution Accrual
CharitableContributionAccrual
3333000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6470000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6885000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15483000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17681000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105647000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
112755000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12957000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12718000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
628000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
686000 shares
CY2020Q1 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
104000 shares
CY2019Q1 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
161000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
469000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
621000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14158000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14186000 shares
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000.0 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000.0 USD
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
17501 shares
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4000000.0 USD
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
179700000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11917000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14053000 USD
CY2020Q1 us-gaap Share Price
SharePrice
183.39
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
138.29
CY2020Q1 us-gaap Share Price
SharePrice
183.39
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3061000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7752000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.192
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.076
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 Rate
CY2020Q1 tree Excess Tax Benefiton Stock Compensation Income Tax Expense Benefit
ExcessTaxBenefitonStockCompensationIncomeTaxExpenseBenefit
-1100000 USD
CY2020Q1 tree Cares Act Income Tax Expense Benefit
CARESActIncomeTaxExpenseBenefit
-6100000 USD
CY2020Q1 tree Cares Act Income Tax Expense Benefit
CARESActIncomeTaxExpenseBenefit
-6100000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 Rate
CY2019Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
6000000.0 USD
CY2020Q1 tree Income Tax Expense Excluding Excess Tax Benefiton Stock Compensation
IncomeTaxExpenseExcludingExcessTaxBenefitonStockCompensation
4097000 USD
CY2019Q1 tree Income Tax Expense Excluding Excess Tax Benefiton Stock Compensation
IncomeTaxExpenseExcludingExcessTaxBenefitonStockCompensation
-1749000 USD
CY2020Q1 tree Excess Tax Benefiton Stock Compensation Income Tax Expense Benefit
ExcessTaxBenefitonStockCompensationIncomeTaxExpenseBenefit
-1054000 USD
CY2019Q1 tree Excess Tax Benefiton Stock Compensation Income Tax Expense Benefit
ExcessTaxBenefitonStockCompensationIncomeTaxExpenseBenefit
-6003000 USD
CY2020Q1 tree Cares Act Income Tax Expense Benefit
CARESActIncomeTaxExpenseBenefit
-6104000 USD
CY2019Q1 tree Cares Act Income Tax Expense Benefit
CARESActIncomeTaxExpenseBenefit
0 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3061000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7752000 USD
CY2017Q2 us-gaap Convertible Debt
ConvertibleDebt
300000000.0 USD
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2017Q2 tree Debt Conversion Numberof Sharesof Common Stock Convertibleper1000of Principal Notes
DebtConversionNumberofSharesofCommonStockConvertibleper1000ofPrincipalNotes
4.8163 shares
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
207.63
CY2017Q2 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
1.30 Rate
CY2017Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
5 day
CY2017Q2 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
5 day
CY2017Q2 tree Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger Five Business Days
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTriggerFiveBusinessDays
0.98 Rate
CY2017Q2 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
1.30 Rate
CY2017Q2 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1 Rate
CY2017Q2 tree Nonconvertible Debt Borrowing Rateatthe Dateof Issuance
NonconvertibleDebtBorrowingRateattheDateofIssuance
0.0536 Rate
CY2017Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
238400000 USD
CY2017Q2 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
61600000 USD
CY2017Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
9300000 USD
CY2017Q2 tree Debtissuancecostsliabilitycomponent
Debtissuancecostsliabilitycomponent
7400000 USD
CY2017Q2 tree Debtissuancecostsequitycomponent
Debtissuancecostsequitycomponent
1900000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
4000000.0 USD
CY2020Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
500000 USD
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3100000 USD
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3800000 USD
CY2019Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
500000 USD
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3000000.0 USD
CY2020Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
337100000 USD
CY2020Q1 us-gaap Convertible Debt
ConvertibleDebt
299985000 USD
CY2019Q4 us-gaap Convertible Debt
ConvertibleDebt
299991000 USD
CY2020Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
28677000 USD
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
31789000 USD
CY2020Q1 tree Debtissuancecostsliabilitycomponent
Debtissuancecostsliabilitycomponent
3438000 USD
CY2019Q4 tree Debtissuancecostsliabilitycomponent
Debtissuancecostsliabilitycomponent
3811000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
267870000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
264391000 USD
CY2017Q2 tree Netproceedsfromthe Convertible Notesusedtopayforthecostofthe Convertible Note Hedge
NetproceedsfromtheConvertibleNotesusedtopayforthecostoftheConvertibleNoteHedge
18100000 USD
CY2017Q2 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
61500000 USD
CY2017Q2 tree Numberof Shares Coveredbythe Hedge Transactions
NumberofSharesCoveredbytheHedgeTransactions
1400000 shares
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
207.63
CY2017Q2 tree Numberof Shares Coveredbythe Hedge Transactions
NumberofSharesCoveredbytheHedgeTransactions
1400000 shares
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
266.39
CY2017Q2 tree Premiumofwarrantstrikepriceoversalespriceofcommonstock
Premiumofwarrantstrikepriceoversalespriceofcommonstock
0.70 Rate
CY2017Q2 us-gaap Share Price
SharePrice
156.70
CY2017Q2 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
43400000 USD
CY2017Q2 tree Netproceedsfromthe Convertible Notesusedtopayforthecostofthe Convertible Note Hedge
NetproceedsfromtheConvertibleNotesusedtopayforthecostoftheConvertibleNoteHedge
18100000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
130000000.0 USD
CY2020Q1 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0221
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
75000000.0 USD
CY2019Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0301
CY2019Q4 tree Credit Agreement Potential Additional Borrowing Capacity
CreditAgreementPotentialAdditionalBorrowingCapacity
185000000.0 USD
CY2020Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 USD
CY2019Q4 tree Ratioof Debtto Ebitda Step Down
RatioofDebttoEBITDAStepDown
4.0
CY2019Q4 tree Ratioof Debtto Ebitda Increase
RatioofDebttoEBITDAIncrease
0.5
CY2020Q1 us-gaap Debt Instrument Unused Borrowing Capacity Fee
DebtInstrumentUnusedBorrowingCapacityFee
300000 USD
CY2019Q1 us-gaap Debt Instrument Unused Borrowing Capacity Fee
DebtInstrumentUnusedBorrowingCapacityFee
100000 USD
CY2020Q1 us-gaap Litigation Reserve
LitigationReserve
600000 USD
CY2019Q4 us-gaap Litigation Reserve
LitigationReserve
200000 USD
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
33464000 USD
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
38837000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8122000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
14592000 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
0 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
0 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-3000000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-4000000 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
22342000 USD
CY2019Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
49429000 USD
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2020Q1 us-gaap Revenues
Revenues
283084000 USD
CY2020Q1 tree Costof Revenueand Marketing Expense
CostofRevenueandMarketingExpense
173869000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
109215000 USD
CY2020Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
13166000 USD
CY2020Q1 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
22755000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32082000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10963000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3378000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13757000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-8122000 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
158000 USD
CY2020Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
329000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20749000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
4834000 USD
CY2020Q1 us-gaap Other Income
OtherIncome
0 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15915000 USD
CY2019Q1 us-gaap Revenues
Revenues
262390000 USD
CY2019Q1 tree Costof Revenueand Marketing Expense
CostofRevenueandMarketingExpense
155872000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
106518000 USD
CY2019Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
10334000 USD
CY2019Q1 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
26355000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31117000 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10166000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2482000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13427000 USD
CY2019Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
14592000 USD
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
54000 USD
CY2019Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
207000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1802000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
5468000 USD
CY2019Q1 us-gaap Other Income
OtherIncome
68000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7202000 USD
CY2017Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.00625 Rate
CY2013Q4 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
61000000.0 USD
CY2020Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0 USD
CY2019Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0 USD
CY2020Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-6102000 USD
CY2019Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1344000 USD
CY2020Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1527000 USD
CY2019Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-282000 USD
CY2020Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-4575000 USD
CY2019Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1062000 USD

Files In Submission

Name View Source Status
0001434621-20-000025-index-headers.html Edgar Link pending
0001434621-20-000025-index.html Edgar Link pending
0001434621-20-000025.txt Edgar Link pending
0001434621-20-000025-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ltlogogradient.jpg Edgar Link pending
mdaq12020historicalmixchart.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tree-20200331.xsd Edgar Link pending
tree-20200331_cal.xml Edgar Link unprocessable
tree-20200331_def.xml Edgar Link unprocessable
tree-20200331_lab.xml Edgar Link unprocessable
tree-20200331_pre.xml Edgar Link unprocessable
tree-2020331x10q.htm Edgar Link pending
tree-2020331x10qexx311.htm Edgar Link pending
tree-2020331x10qexx312.htm Edgar Link pending
tree-2020331x10qexx321.htm Edgar Link pending
tree-2020331x10qexx322.htm Edgar Link pending
tree-2020331x10q_htm.xml Edgar Link completed